The study underscores the importance of defining the appropriate delivery form of an immune adjuvant, such as GM-CSF, relative to the immunization strategy to maximize the host immune responses against a specific antigen.
Meriva is a patented delivery form of the dietary phenolic curcumin, resorting to the use of lecithin (from non-GMO sources) to boost the absorption and bioavailability.
In this study, we used Meriva, a novel bioavailable lecithin based delivery form of curcumin [ 26] as an adjuvant therapy for the treatment of patients with mild-to-moderate psoriasis vulgaris.
In conclusion, our study demonstrated that Meriva, a novel lecithin based delivery form of curcumin, can be regarded as a safe and effective ingredient, useful for the adjuvant therapy of patients with mild-to-moderate plaque psoriasis vulgaris treated with topical steroids.
This study aims to assess patient acceptability of the delivery form and components of Internet-enabled programmes based on home groups for comprehensive pulmonary rehabilitation and for diabetes self-management education.
The purpose of this feasibility study was to assess patient acceptability of the delivery form and the components of the home programmes.
We also monitored the following outcomes: mode of delivery, other forms of pain relief, augmentation of labour, duration of labour, perineal trauma, newborn Apgar score, umbilical cord pH and Base Excess, and transfer of the infant to neonatal clinic.
Individual data collection forms, designed as part of the cohort study, documented duration of labour, mode of delivery, some forms of pain relief, active management of the third stage of labour, whether an episiotomy was performed, clinical complications, length of stay for both mother and baby by type of ward and level of care, and transfers by duration and mode.
In this paper, we assess patient acceptability of the delivery form and the programme components.
